Metrics
Publication
322
Open Access
34
UN Sustainable Development Goals
Education Information
2000 - 2003
2000 - 2003Post Doctorate of Medicine
Marmara University, Tıp Faültesi, Tıbbi Onkoloji Bd, Turkey
1994 - 1998
1994 - 1998Expertise In Medicine
Sağlık Bakanlığı, Dr.Lütfi Kırdar Eah, İç Hastalıkları Kliniği, Turkey
1983 - 1989
1983 - 1989Undergraduate
Istanbul University, Istanbul Medical Faculty, Turkey
Certificates, Courses and Trainings
2011
2011Yönetim Yeteneklerini Geliştirme
Health&Medicine
Partner Danışmanlık
Research Areas
Health Sciences, Medicine, Internal Medicine Sciences, Internal Diseases , Oncology
Academic Titles / Tasks
2016 - Continues
2016 - ContinuesProfessor
Istanbul Medeniyet University, Faculty Of Medicine, Internal Medical Sciences
Managerial Experience
2016 - Continues
2016 - ContinuesUniversity Executive Board Member
İstanbul Medeniyet Üniversitesi
2016 - 2016
2016 - 2016Head of Ethics Committee
Bezmialem Vakıf Üniversitesi, Girişimsel Olmayan Araştırmalar Etik Kurulu
2014 - 2016
2014 - 2016Rectorate Commissioner
Bezmialem Vakıf Üniversitesi, Mevzuat Komisyonu Başkanı
2014 - 2015
2014 - 2015University Executive Board Member
Bezmialem Vakıf Üniversitesi
2014 - 2015
2014 - 2015Rector's Advisor
Bezmialem Vakıf Üniversitesi
Published journal articles indexed by SCI, SSCI, and AHCI
2022
2022Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study
Artac M., Cubukcu E., Bozkurt O., Bilici A., Celik S., Ozcelik M., et al.
ANNALS OF ONCOLOGY, vol.33, 2022 (Peer-Reviewed Journal)
2022
2022Phase 2 study of pembrolizumab-based combination therapy in patients with microsatellite instability-high or mismatch repair-deficient stage IV colorectal cancer
Andre T., Sposetti C., GÜMÜŞ M., Ahn J. B. , Wyrwicz L., Kwiatkowski M., et al.
ANNALS OF ONCOLOGY, vol.33, 2022 (Peer-Reviewed Journal)
2022
2022Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: safety and patient-reported outcomes from the monarchE study
Rugo H. S. , O'Shaughnessy J., Boyle F., Toi M., Broom R., Blancas I., et al.
ANNALS OF ONCOLOGY, vol.33, no.6, pp.616-627, 2022 (Peer-Reviewed Journal)
2022
2022First-line anti-EGFR agents (panitumumab or cetuximab) plus chemotherapy in patients with metastatic colorectal cancer: Onco-colon Turkey study subgroup analysis
Isikdogan A., Turk H., Bilir C., Sendur M., Karabulut B., Artac M., et al.
ANNALS OF ONCOLOGY, vol.33, 2022 (Peer-Reviewed Journal)
2022
2022Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy?
Dulgar O., Oven B. B. , Atci M. M. , Arikan R., AY S., Ayhan M., et al.
EXPERT REVIEW OF ANTICANCER THERAPY, 2022 (Peer-Reviewed Journal)
2022
2022Patient-reported outcomes (PROs) with first-line (1L) cemiplimab in patients with locally advanced non-small cell lung cancer (laNSCLC): EMPOWER-Lung 1 subpopulation
Bondarenko I., Sezer A., Kilickap S., GÜMÜŞ M., ÖZGÜROĞLU M., Gogishvili M., et al.
ANNALS OF ONCOLOGY, vol.33, 2022 (Peer-Reviewed Journal)
2022
2022First-line pembrolizumab (pembro) with or without lenvatinib (lenva) in patients with advanced urothelial carcinoma (LEAP-011): A phase 3, randomized, double-blind study.
Loriot Y., Grivas P., De Wit R., Balar A. V. , Siefker-Radtke A. O. , Zolnierek J., et al.
JOURNAL OF CLINICAL ONCOLOGY, vol.40, no.6, 2022 (Peer-Reviewed Journal)
2022
2022Surgical, pathological and clinical features of advanced collorectal cancers with metastasectomy. "Onco-Colon Turkey Registry" real-life data
Karadurmus N., Yildirim E., Yalcin S., Gumus M., Bilir C., Cubukcu E., et al.
JOURNAL OF CLINICAL ONCOLOGY, vol.40, no.4, 2022 (Peer-Reviewed Journal)
2022
2022Role of tumor location on high-grade serous ovarian cancer prognosis.
Ay S., Tataroğlu Özyükseler D., Başak M., Dülgar Ö., Arıcı S., Yıldırım M. E. , et al.
Ginekologia polska, vol.93, pp.284-289, 2022 (Peer-Reviewed Journal)
2022
2022FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer
AY S., Atci M. M. , Arikan R., Dulgar O., Ozyukseler D. T. , Paksoy N., et al.
JOURNAL OF CHEMOTHERAPY, 2022 (Peer-Reviewed Journal)
2021
2021Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer.
Colombo N., Dubot C., Lorusso D., Caceres M., Hasegawa K., Shapira-Frommer R., et al.
The New England journal of medicine, vol.385, pp.1856-1867, 2021 (Peer-Reviewed Journal)
2021
2021PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma.
Sahinli H., Akyürek N., Yılmaz M., Kandemir O., Duran A. O. , Kulaçoğlu S., et al.
Indian journal of cancer, vol.58, pp.561-566, 2021 (Peer-Reviewed Journal)
2021
2021Clinical Benefit of First-Line Cemiplimab in Patients with Locally Advanced NSCLC: Subgroup Analysis from EMPOWER-Lung 1
Bondarenko I., Sezer A., Kilickap S., GÜMÜŞ M., ÖZGÜROĞLU M., Gogishvili M., et al.
JOURNAL OF THORACIC ONCOLOGY, vol.16, no.10, 2021 (Peer-Reviewed Journal)
2021
2021Is the duration of castration resistance predictive for sequential treatment responses in the metastatic castration-resistant prostate cancer setting?
Dülgar Ö., Özyükseler D., Başak M., Ay S., Tural D., Yıldırım M., et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, vol.27, pp.1388-1394, 2021 (Peer-Reviewed Journal)
2021
2021Initial Ca 125 Value as a Predictive Marker for High-grade Serous Ovarian Cancer.
Ay S., Ozyukseler D. T. , Dulgar O., Basak M., Yildirim M. E. , Gumus M.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, vol.30, no.6, pp.651-656, 2021 (Peer-Reviewed Journal)
2021
2021Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective
ÇİÇİN İ., Oksuz E., Karadurmus N., Malhan S., GÜMÜŞ M., Yilmaz U., et al.
HEALTH ECONOMICS REVIEW, vol.11, no.1, 2021 (Peer-Reviewed Journal)
2021
2021Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer.
Kefeli U., Arslan C., Yildirim M. E. , Isikdogan A., Karadurmus N., Karabulut B., et al.
JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.15, 2021 (Peer-Reviewed Journal)
2021
2021Cemiplimab monotherapy as first-line (1L) treatment of patients with brain metastases from advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) >= 50%: EMPOWER-Lung 1 subgroup analysis.
Ozguroglu M., Sezer A., Kilickap S., Gumus M., Bondarenko I., Gogishvili M., et al.
JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.15, 2021 (Peer-Reviewed Journal)
2021
2021Patient-reported symptoms, functioning, and quality of life (QoL) in patients treated with cemiplimab monotherapy for first-line treatment of advanced NSCLC with PD-L1 >= 50%: Results from EMPOWER-Lung 1 study.
Gumus M., Chen C., Ivanescu C., Kilickap S., Bondarenko I., Ozguroglu M., et al.
JOURNAL OF CLINICAL ONCOLOGY, vol.39, no.15, 2021 (Peer-Reviewed Journal)
2021
2021Safety outcomes from monarchE: Phase 3 study of abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER-2-, node-positive, high risk, early breast cancer
Rugo H., O'Shaughnessy J., Song C., Broom R., Gumus M., Yamashita T., et al.
BREAST, vol.56, 2021 (Peer-Reviewed Journal)
2021
2021Clinical Benefits of First-Line (1L) Cemiplimab Monotherapy by PD-L1 Expression Levels in Patients With Advanced NSCLC
Kilickap S., Sezer A., Gumus M., Bondarenko I., Ozguroglu M., Gogishvili M., et al.
JOURNAL OF THORACIC ONCOLOGY, vol.16, no.3, 2021 (Peer-Reviewed Journal)
2021
2021High Ki-67 as a biomarker for identifying patients with high risk early breast cancer treated in monarchE
Harbeck N., Johnston S., Fasching P., Martin M., Toi M., Rastogi P., et al.
CANCER RESEARCH, vol.81, no.4, 2021 (Peer-Reviewed Journal)
2021
2021Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
Sezer A., KILIÇKAP S., GÜMÜŞ M., Bondarenko I., ÖZGÜROĞLU M., Gogishvili M., et al.
LANCET, vol.397, no.10274, pp.592-604, 2021 (Peer-Reviewed Journal)
2020
2020Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study
Benekli M., Gumus M., ÖZKAN M., Dane F., ELKIRAN E. T. , Cicin I., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020 (Peer-Reviewed Journal)
2020
2020Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study.
Rudin C., Awad M., Navarro A., Gottfried M., Peters S., Csőszi T., et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.38, pp.2369-2379, 2020 (Peer-Reviewed Journal)
2020
2020Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial.
Galsky M., Arija J., Bamias A., Davis I., De S., Kikuchi E., et al.
Lancet (London, England), vol.395, pp.1547-1557, 2020 (Peer-Reviewed Journal)
2020
2020KEYNOTE-604: Pembrolizumab (pembro) or placebo plus etoposide and platinum (EP) as first-line therapy for extensive-stage (ES) small-cell lung cancer (SCLC).
Rudin C. M. , Awad M. M. , Navarro A., Gottfried M., Peters S., Csoszi T., et al.
JOURNAL OF CLINICAL ONCOLOGY, vol.38, no.15, 2020 (Peer-Reviewed Journal)
2020
2020Health-Related Quality of Life With Carboplatin-Paclitaxel or nab-Paclitaxel With or Without Pembrolizumab in Patients With Metastatic Squamous Non-Small-Cell Lung Cancer.
Mazieres J., Kowalski D., Luft A., Vicente D., Tafreshi A., Gümüş M., et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.38, pp.271-280, 2020 (Peer-Reviewed Journal)
2019
2019Nutritional Aspect of Cancer Care in Medical Oncology Patients.
Yalcin S., Gumus M., Oksuzoglu B., Ozdemir F., Evrensel T., Sarioglu A., et al.
Clinical therapeutics, 2019 (Peer-Reviewed Journal)
2019
2019Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre Study.
Kaplan M., Ozaydin S., Yerlikaya H., Karaagac M., Gumus M., Cil T., et al.
Oncology research and treatment, vol.42, pp.516-522, 2019 (Peer-Reviewed Journal)
2019
2019Cemiplimab, a Human PD-1 Monoclonal Antibody, Versus Chemotherapy in First-Line Treatment of Advanced NSCLC with PD-L1 >= 50%
Sezer A., Gogishvili M., Bentsion D., KILIÇKAP S., Lowczak A., GÜMÜŞ M., et al.
JOURNAL OF THORACIC ONCOLOGY, vol.14, no.10, 2019 (Peer-Reviewed Journal)
2019
2019The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study
Kaplan M. A. , Oruc Z., Gumus M., Ozaydm S., ELKIRAN E. T. , Dine N. S. , et al.
JOURNAL OF BUON, vol.24, no.3, pp.1081-1086, 2019 (Peer-Reviewed Journal)
2019
2019Association of lymphadenectomy and survival in epithelial ovarian cancer
Ercelep O., Ozcelik M., Gumus M.
CURRENT PROBLEMS IN CANCER, vol.43, no.2, pp.151-159, 2019 (Peer-Reviewed Journal)
2019
2019Comparison of clinicopathologic and survival characteristics of high grade endometrial cancers; single center experience
Ercelep O., Gumus M.
CURRENT PROBLEMS IN CANCER, vol.43, no.2, pp.160-166, 2019 (Peer-Reviewed Journal)
2019
2019Retrospective evaluation of patients diagnosed solid pseudopapillary neoplasms of the pancreas
Ercelep O., Ozdemir N., Turan N., Topcu T. O. , Uysal M., Tanriverdi O., et al.
CURRENT PROBLEMS IN CANCER, vol.43, no.1, pp.27-32, 2019 (Peer-Reviewed Journal)
2019
2019Changes in Sexual Function of Patients with Cancer in Turkey
Cil Akinci A., Cosar Cetin F., Tuna R., Zengin N., Gumus M.
Sexuality and Disability, 2019 (Peer-Reviewed Journal)
2018
2018Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer.
Paz-Ares L., Luft A., Vicente D., Tafreshi A., Gümüş M., MAZIÈRES J., et al.
The New England journal of medicine, vol.379, pp.2040-2051, 2018 (Peer-Reviewed Journal)
2018
2018EGFR Mutation in Patients with NSCLC and Its Relationship Between Survival and Clinicopathological Features: An Update Analysis
OZTURK A., CELIK S., Kodaz H., Yildiz I., Ocak A., Hacibekiroglu I., et al.
JOURNAL OF THORACIC ONCOLOGY, vol.13, no.10, 2018 (Peer-Reviewed Journal)
2018
2018Choice of Taxane and Outcomes in the KEYNOTE-407 Study of Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC
Halmos B., Luft A., Majem M., Hui R., Corre R., Gumus M., et al.
JOURNAL OF THORACIC ONCOLOGY, vol.13, no.10, 2018 (Peer-Reviewed Journal)
2018
2018Phase 3 study of carboplatin-paclitaxel/nab-paclitaxel (Chemo) with or without pembrolizumab (Pembro) for patients (Pts) with metastatic squamous (Sq) non-small cell lung cancer (NSCLC).
Paz-Ares L. G. , Luft A., Tafreshi A., Gumus M., Mazieres J., Hermes B., et al.
JOURNAL OF CLINICAL ONCOLOGY, vol.36, no.15, 2018 (Peer-Reviewed Journal)
2018
2018Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report.
AYGEN B., DEMIR A., Gümüş M., KARABAY O., KAYMAKOĞLU S., KÖKSAL A., et al.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, vol.29, pp.259-269, 2018 (Peer-Reviewed Journal)
2018
2018Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)
INAL A., Kodaz H., ODABAS H., Duran A., Seker M., INANC M., et al.
Journal of Cancer Research and Therapeutics, vol.14, no.3, pp.578-582, 2018 (Peer-Reviewed Journal)
2018
2018A comparison of metacognitive factors among patients with cancer and the control group
Mutlu H. H. , BILICAN F., Mutlu H., Gumus M.
PSYCHO-ONCOLOGY, vol.27, no.4, pp.1277-1283, 2018 (Peer-Reviewed Journal)
2018
2018Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study
Demirci A., Alkis N., DANE F., Durnali A., Yazici O. K. , Rzayev R., et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, vol.14, no.2, 2018 (Peer-Reviewed Journal)
2018
2018Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia.
SEVINC A., OZKAN M. A. , OZET A., DANE F., ÖKSÜZOĞLU B., IŞıKDOĞAN A., et al.
OncoTargets and therapy, vol.11, pp.419-426, 2018 (Peer-Reviewed Journal)
2017
2017EGFR Mutation and Erlotinib Efficacy in Turkish Oncoregistry
Gumus M., Ozkan M., Yilmaz U., Tekin S. B. , Demir C., Erdogan A., et al.
JOURNAL OF THORACIC ONCOLOGY, vol.12, no.11, 2017 (Peer-Reviewed Journal)
2017
2017ECONOMIC BURDEN OF GASTRIC CANCER IN TURKEY
Bilici A., Gumus M., Malhan S., Oksuz E., OKSUZOGLU B., Yalcm S.
VALUE IN HEALTH, vol.20, no.9, 2017 (Peer-Reviewed Journal)
2017
2017Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection
Aydin D., Sendur M. A. , KEFELİ U., Unal O. U. , Tastekin D., Akyol M., et al.
CLINICAL COLORECTAL CANCER, vol.16, no.3, pp.220-227, 2017 (Peer-Reviewed Journal)
2017
2017Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer.
KAYA S., AKTAS B., Tanrikulu S., Akif O., DEDE F., KAYA H., et al.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, vol.22, pp.1191-1198, 2017 (Peer-Reviewed Journal)
2017
2017Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer
Kaya S., Aktas B., Sismek E. T. , Ozturk M. A. , DEDE F., KAYA H., et al.
JOURNAL OF BUON, vol.22, no.5, pp.1191-1198, 2017 (Peer-Reviewed Journal)
2017
2017Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
Gumus M., BILICI A., ODABAS H., USTAALIOGLU B., KANDEMIR N., DEMIRCI U., et al.
World journal of urology, vol.35, pp.1103-1110, 2017 (Peer-Reviewed Journal)
2017
2017Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma
Aydin D., Sendur M. A. , KEFELİ U., Ustaalioglu B. B. , Aydin O., Yildirim E., et al.
CLINICAL COLORECTAL CANCER, vol.16, no.1, pp.78-83, 2017 (Peer-Reviewed Journal)
2017
2017Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort.
AKSOY A., ODABAS H., KAYA S., BOZKURT O., DEGIRMENCI M., TOPCU T., et al.
Saudi medical journal, vol.38, pp.156-162, 2017 (Peer-Reviewed Journal)
2016
2016The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker.
YıLDıRıM M., KEFELI U., AYDIN D., SENER N., Gümüş M.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol.37, pp.11903-11907, 2016 (Peer-Reviewed Journal)
2016
2016Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology.
ERCELEP O., TOPCU T., BAYOGLU I., EKINCI A., KOCA S., KAVGACI H., et al.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol.37, pp.12033-12038, 2016 (Peer-Reviewed Journal)
2016
2016Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients
OZCELIK M., KORKMAZ T., ODABAS H., GEMICI C., ERCELEP O., YUKSEL S., et al.
TUMOR BIOLOGY, vol.37, no.7, pp.8901-8907, 2016 (Peer-Reviewed Journal)
2016
2016The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients
OZCELIK M., ODABAS H., ERCELEP O., YUKSEL S., MERT A. G. , AYDIN D., et al.
CLINICAL & TRANSLATIONAL ONCOLOGY, vol.18, no.6, pp.617-624, 2016 (Peer-Reviewed Journal)
2016
2016Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology
OZCELIK M., SEKER M., ERASLAN E., Koca S., YAZILITAS D., ERCELEP O., et al.
TUMOR BIOLOGY, vol.37, no.4, pp.5231-5237, 2016 (Peer-Reviewed Journal)
2016
2016The prognostic value of beta-catenin and LEF-1 expression in patients with operable gastric carcinoma
Kaya S., Gumus M., Gurbuz Y., ÇABUK D., Acikgoz O., Temiz S., et al.
AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, vol.8, no.2, pp.1228-1236, 2016 (Peer-Reviewed Journal)
2016
2016Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO).
AYDIN D., Sendur M., KEFELI U., Umut U., TASTEKIN D., AKYOL M., et al.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, vol.21, pp.1242-1249, 2016 (Peer-Reviewed Journal)
2016
2016Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer.
DINC N., AYDıN K., ODABAS H., ERCELEP O., TUFAN G., SEKER M., et al.
Oncology research and treatment, vol.39, pp.130-4, 2016 (Peer-Reviewed Journal)
2015
2015Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology.
ODABAS H., ULAS A., AYDıN K., INANC M., AKSOY A., YAZILITAS D., et al.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol.36, pp.9641-8, 2015 (Peer-Reviewed Journal)
2015
2015Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.
BILICI A., OZTURK T., TURKMEN E., ODABAS H., CIHAN S., SELCUKBIRICIK F., et al.
World journal of urology, vol.33, pp.1613-22, 2015 (Peer-Reviewed Journal)
2015
2015The changing of serum vitamin B12 and homocysteine levels after gastrectomy in patients with gastric cancer: do they associate with clinicopathological factors?
BILICI A., SONKAYA A., ERCAN S., USTAALIOGLU B., SEKER M., ALIUSTAOGLU M., et al.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, vol.36, pp.823-8, 2015 (Peer-Reviewed Journal)
2015
2015Evaluation of Managerial Needs for Palliative Care Centers: Perspectives of Medical Directors.
KAFADAR D., INCE N., AKCAKAYA A., Gumus M.
Asian Pacific journal of cancer prevention : APJCP, vol.16, pp.4653-8, 2015 (Peer-Reviewed Journal)
2015
2015A Pilot Study of Self-Reported Physical Activity and Eating Habits in Turkish Cancer Patients Under Chemotherapy.
GUNES-BAYIR A., KIZILTAN H., SENTÜRK N., MAYADAGLI A., Gumus M.
Nutrition and cancer, vol.67, pp.906-11, 2015 (Peer-Reviewed Journal)
2014
2014Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.
TURAN N., BENEKLI M., DANE F., UNAL O., KARA H., KOCA D., et al.
Thoracic cancer, vol.5, pp.398-404, 2014 (Peer-Reviewed Journal)
2014
2014Important Factors Affecting Adjuvant Treatment Decision in Stage IA Breast Cancer Patients in Turkey.
Oven U., BILICI A., YILMAZ B., ALIUSTAOGLU M., SEKER M., VARDAR F., et al.
Breast care (Basel, Switzerland), vol.9, pp.123-7, 2014 (Peer-Reviewed Journal)
2014
2014End-of-study results of Turkish gastric cancer patients from the global REGATE study
YALÇIN Ş., Gumus M., KILIÇKAP S., ALKIS N., ILHAN M., OKSUZOGLU B., et al.
JOURNAL OF BUON, vol.19, no.2, pp.377-387, 2014 (Peer-Reviewed Journal)
2014
2014Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology
Gumusay O., Coskun U., AKMAN T., EKINCI A. S. , Kocar M., ERCELEB O. B. , et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.140, no.1, pp.151-157, 2014 (Peer-Reviewed Journal)
2014
2014Treatment modalities in primary gastric lymphoma: The effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology
Mehmet K., SENER C., UYETURK U., SEKER M., Tastekin D., Tonyali O., et al.
Wspolczesna Onkologia, vol.18, no.4, pp.273-278, 2014 (Peer-Reviewed Journal)
2014
2014Prognostic significance of protein kinase B/Akt pathway in patients with non-small cell lung cancer.
MAYADAGLI A., Karabulut G., BILICI A., Fatih O., KOCAK M., OZKAN A., et al.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, vol.19, pp.157-63, 2014 (Peer-Reviewed Journal)
2014
2014Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.
BILICI A., INANC M., ULAS A., AKMAN T., SEKER M., BABACAN N., et al.
Asian Pacific journal of cancer prevention : APJCP, vol.14, pp.6493-9, 2014 (Peer-Reviewed Journal)
2013
2013Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab
Tonyali O., Coskun U., SENER N., İNANÇ M., Akman T., ULAS A., et al.
ONKOLOGIE, vol.36, no.10, pp.554-558, 2013 (Peer-Reviewed Journal)
2013
2013Primary renal carcinoid: Treatment and prognosis
KORKMAZ T., Seber S., YAVUZER D., Gumus M., Turhal N. S.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol.87, no.3, pp.256-264, 2013 (Peer-Reviewed Journal)
2013
2013Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience
KEFELI U., Benekli M., Sevinc A., YILDIZ R., Kaplan M. A. , Ciltas A., et al.
ONCOLOGY LETTERS, vol.6, no.2, pp.605-611, 2013 (Peer-Reviewed Journal)
2013
2013Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis
KORKMAZ T., Seber S., KEFELI U., SARI E., Canhoroz M., OVEN B., et al.
CLINICAL & TRANSLATIONAL ONCOLOGY, vol.15, no.7, pp.535-540, 2013 (Peer-Reviewed Journal)
2013
2013Efficacy of Sunitinib in Turkish Patients with Gastrointestinal Stromal Tumors; Retrospective Multicenter Experience
KEFELI U., Buyukberber S., AKYOL M., YILDIZ R., Kaplan M. A. , Ciltas A., et al.
HEPATO-GASTROENTEROLOGY, vol.60, no.124, pp.647-652, 2013 (Peer-Reviewed Journal)
2013
2013The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer
USTAALIOGLU B. B. O. , BILICI A., ERCAN S., SEKER M., ORCUN A., Gumus M.
MEDICAL ONCOLOGY, vol.30, no.2, 2013 (Peer-Reviewed Journal)
2013
2013Prognostic Factors in Gastrointestinal Stromal Tumors: Multicenter Experience of 333 Cases from Turkey
SEKER M., SEVINC A., Yildiz R., CIHAN S., Kaplan M. A. , GOKDURNALI A., et al.
HEPATO-GASTROENTEROLOGY, vol.60, no.124, pp.768-775, 2013 (Peer-Reviewed Journal)
2013
2013Large cell neuroendocrine carcinoma: retrospective analysis of 24 cases from four oncology centers in Turkey
USTAALIOGLU B. B. O. , ULAS A., ESBAH O., Turan N., BILICI A., DEMIRCI U., et al.
THORACIC CANCER, vol.4, no.2, pp.161-166, 2013 (Peer-Reviewed Journal)
2013
2013The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy
BILICI A., Salman T., USTAALIOGLU B. B. O. , Unek T., SEKER M., ALIUSTAOGLU M., et al.
JOURNAL OF SURGICAL RESEARCH, vol.180, no.1, 2013 (Peer-Reviewed Journal)
2013
2013Childhood, Adolescents, and Young Adults (<= 25 y) Colorectal Cancer: Study of Anatolian Society of Medical Oncology
Kaplan M. A. , Isikdogan A., Gumus M., ARSLAN U. Y. , Geredeli C., OZDEMIR N., et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, vol.35, no.2, pp.83-89, 2013 (Peer-Reviewed Journal)
2013
2013Xeliri Plus Bevacizumab Compared with Folfiri Plus Bevacizumab as First-Line Setting in Patients with Metastatic Colorectal Cancer: Experiences at Two-Institutions
UYGUN K., BILICI A., Kaya S., USTAALIOGLU B. B. O. , YILDIZ R., Temiz S., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, no.4, pp.2283-2288, 2013 (Peer-Reviewed Journal)
2013
2013Prognostic Factors for Lymph Node Negative Stage I and IIA Non-small Cell Lung Cancer: Multicenter Experiences
USTAALIOGLU B. B. O. , Unal O. U. , Turan N., Bilici A., Kaya S., EREN T., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, no.11, pp.6287-6292, 2013 (Peer-Reviewed Journal)
2013
2013Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience
Cetin B., Benekli M., DANE F., Boruban C., Gumus M., OKSUZOGLU B., et al.
BREAST CARE, vol.8, no.1, pp.67-70, 2013 (Peer-Reviewed Journal)
2013
2013Efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma: A Retrospective Study by the Anatolian Society of Medical Oncology
Berk V., Kaplan M. A. , Tonyali O., Buyukberber S., Balakan O., ÖZKAN M., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, no.12, pp.7367-7369, 2013 (Peer-Reviewed Journal)
2013
2013Salvage Treatment Experience in Advanced Synovial Sarcoma: a Multicenter Retrospective Analysis of the Anatolian Society of Medical Oncology
Yetisyigit T., ARPACI E., Seber E. S. , Kucukoner M., KOS F. T. , SONMEZ O. U. , et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, no.9, pp.5185-5188, 2013 (Peer-Reviewed Journal)
2013
2013Low-Dose Docetaxel/Cisplatin - Leucovorin and 46 Hour Infusional Fluorouracil in Metastatic Gastric Carcinoma
ALICI S., Buyukberber S., Alkis N., Benekli M., ÖZKAN M., Bilici A., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, no.1, pp.423-427, 2013 (Peer-Reviewed Journal)
2012
2012Clinical outcomes among ErbB2+MBC patients treated with lapatinib-capecitabine after trastuzumab progression: Role of early switch to lapatinib (TYCO study).
ABULKHAIR O., USLU R., SEZGIN C., BUEYUEKBERBER S., DARWISH T., ISIKDOGAN A., et al.
CANCER RESEARCH, vol.72, 2012 (Peer-Reviewed Journal)
2012
2012Gallbladder metastasis secondary to gastric cancer as a first site of recurrence presented with acute cholecystitis: Case report and literature review
BILICI A., SEKER M., OVEN USTAALIOGLU B. B. , HALLAC KESER S., CINARAL F., Gumus M.
TURKISH JOURNAL OF GASTROENTEROLOGY, vol.23, no.6, pp.764-768, 2012 (Peer-Reviewed Journal)
2012
2012Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer
Tonyali O., Coskun U., SENER N., İNANÇ M., Akman T., OKSUZOGLU B., et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.138, no.12, pp.2145-2151, 2012 (Peer-Reviewed Journal)
2012
2012The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer
BILICI A., USTAALIOGLU B. B. O. , ERCAN S., SEKER M., YILMAZ B. E. , ORCUN A., et al.
TUMOR BIOLOGY, vol.33, no.6, pp.2201-2208, 2012 (Peer-Reviewed Journal)
2012
2012Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer
USTAALIOGLU B. B. O. , BILICI A., BARISIK N. O. , ALIUSTAOGLU M., VARDAR F. A. , YILMAZ B. E. , et al.
CLINICAL & TRANSLATIONAL ONCOLOGY, vol.14, no.12, pp.911-922, 2012 (Peer-Reviewed Journal)
2012
2012The Importance of Multifocal/Multicentric Tumor on the Disease-Free Survival of Breast Cancer Patients Single Center Experience
USTAALIOGLU B. O. , BILICI A., KEFELI U., SEKER M., ONCEL M., GEZEN C., et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.35, no.6, pp.580-586, 2012 (Peer-Reviewed Journal)
2012
2012Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment
KEFELI U., YILDIRIM M. E. , AYDIN D., MADENCI O. C. , YASAR N., SENER N., et al.
Biomarkers, vol.17, no.7, pp.663-667, 2012 (Peer-Reviewed Journal)
2012
2012Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy
KAYA A. O. , Coskun U., ÖZKAN M., Sevinc A., Yilmaz A. U. , Gumus M., et al.
ONKOLOGIE, vol.35, no.10, pp.576-580, 2012 (Peer-Reviewed Journal)
2012
2012Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
ESER M., KEMENT M., BALIN S., COSKUN C., KEFELI U., Gumus M., et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY, vol.10, 2012 (Peer-Reviewed Journal)
2012
2012The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimens
KAYA A. O. , Coskun U., Gumus M., DANE F., ÖZKAN M., Isikdogan A., et al.
JOURNAL OF CHEMOTHERAPY, vol.24, no.4, pp.217-220, 2012 (Peer-Reviewed Journal)
2012
2012Elective bladder preservation with multimodality treatment for bladder cancer
MAYADAGLI A., KOCAK M., DEMIR O., GUL S. K. , OZKAN A., PARLAK C., et al.
JOURNAL OF BUON, vol.17, no.3, pp.483-489, 2012 (Peer-Reviewed Journal)
2012
2012The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?
BILICI A., YAPICI H. S. , ERCAN S., SEKER M., USTAALIOGLU B. B. O. , Salman T., et al.
JOURNAL OF BUON, vol.17, no.3, pp.502-507, 2012 (Peer-Reviewed Journal)
2012
2012Outcome of non-metastatic male breast cancer: 118 patients
ARSLAN U. Y. , OKSUZOGLU B., OZDEMIR N., AKSOY S., ALKIS N., GOK A., et al.
MEDICAL ONCOLOGY, vol.29, no.2, pp.554-560, 2012 (Peer-Reviewed Journal)
2012
2012Prognostic Significance of High Phosphatase of Regenerating Liver-3 Expression in Patients with Gastric Cancer Who Underwent Curative Gastrectomy
BILICI A., USTAALIOGLU B. B. O. , YAVUZER D., SEKER M., MAYADAGLI A., Gumus M.
DIGESTIVE DISEASES AND SCIENCES, vol.57, no.6, pp.1568-1575, 2012 (Peer-Reviewed Journal)
2012
2012Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls
USTAALIOGLU B. O. , BILICI A., ERCAN S., ORCUN A., SEKER M., OZKAN A., et al.
CLINICAL & TRANSLATIONAL ONCOLOGY, vol.14, no.5, pp.356-361, 2012 (Peer-Reviewed Journal)
2012
2012Taxane-based mono- or combination therapy for managing metastatic breast cancer (MBC) in routine practice: a multinational prospective observational study
Gumus M., DAVIDSON N., BAUKNECHT T., SOLDATENKOVA V., BENHADJI K. A.
CURRENT MEDICAL RESEARCH AND OPINION, vol.28, no.3, pp.401-413, 2012 (Peer-Reviewed Journal)
2012
2012Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors
GEZEN C., KEMENT M., ALTUNTAS Y. E. , OKKABAZ N., SEKER M., VURAL S., et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY, vol.10, 2012 (Peer-Reviewed Journal)
2012
2012Long Term Survivors with Metastatic Pancreatic Cancer Treated with Gemcitabine Alone or Plus Cisplatin: a Retrospective Analysis of an Anatolian Society of Medical Oncology Multicenter Study
Inal A., Ciltas A., YILDIZ R., Berk V., KOS F. T. , DANE F., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.13, no.5, pp.1841-1844, 2012 (Peer-Reviewed Journal)
2012
2012Gemcitabine and Cisplatin Combination Chemotherapy in Triple Negative Metastatic Breast Cancer Previously Treated with a Taxane/Anthracycline Chemotherapy; Multicenter Experience
ÖZKAN M., Berk V., Kaplan M. A. , Benekli M., Coskun U., BILICI A., et al.
NEOPLASMA, vol.59, no.1, pp.38-42, 2012 (Peer-Reviewed Journal)
2012
2012Weekly Topotecan for Recurrent Small Cell Lung Cancer - a Retrospective Anatolian Medical Oncology Group Study
ALTINBAS M., Kalender M. E. , OVEN B., Sevinc A., Karaca H., Kaplan M. A. , et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.13, no.6, pp.2909-2912, 2012 (Peer-Reviewed Journal)
2012
2012Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study
Inal A., KOS F. T. , Algin E., YILDIZ R., Berk V., Unek I. T. , et al.
JOURNAL OF BUON, vol.17, no.1, pp.102-105, 2012 (Peer-Reviewed Journal)
2012
2012Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study
Inal A., KOS F. T. , Algin E., YILDIZ R., Dikiltas M., Unek I. T. , et al.
NEOPLASMA, vol.59, no.3, pp.297-301, 2012 (Peer-Reviewed Journal)
2011
2011Laparoscopic Abdominoperineal Resections for Mid or Low Rectal Adenocarcinomas: A Retrospective, Comparative Study
GEZEN C., ALTUNTAS Y. E. , KEMENT M., OKKABAZ N., BILICI A., VURAL S., et al.
SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, vol.21, no.6, pp.396-402, 2011 (Peer-Reviewed Journal)
2011
2011Is Subdivision of pT2 Tumors Superior to Lymph Node Metastasis for Predicting Survival of Patients with Gastric Cancer? Review of 224 Patients from Four Centers
BILICI A., DANE F., SEKER M., USTAALIOGLU B. B. O. , ALIUSTAOGLU M., Temiz S., et al.
DIGESTIVE DISEASES AND SCIENCES, vol.56, no.11, pp.3226-3234, 2011 (Peer-Reviewed Journal)
2011
2011Tissue and Serum Adiponectin Levels in Patients with Gastric Cancer: Are there any Correlations between Adiponectin Levels and Histopathological Variables?
SEKER M., BILICI A., GULER D. O. , USTAALIOGLU B. B. , GOZU H., ERKAL F. Y. , et al.
HEPATO-GASTROENTEROLOGY, vol.58, no.110, pp.1841-1846, 2011 (Peer-Reviewed Journal)
2011
2011Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience
KEFELI U., KAYA S., USTAALIOGLU B. O. , BILICI A., Kefeli A. U. , YILDIRIM M. E. , et al.
MEDICAL ONCOLOGY, vol.28, no.3, pp.661-666, 2011 (Peer-Reviewed Journal)
2011
2011The value of COX-2 expression in the prognostic parameters of invasive ductal carcinoma of the breast
BARISIK N. O. , KESER S. H. , GUL A. E. , SENSU S., KANDEMIR N. O. , Küçük H. F. , et al.
MEDICAL ONCOLOGY, vol.28, no.3, pp.703-708, 2011 (Peer-Reviewed Journal)
2011
2011Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
BILICI A., USTAALIOGLU B. B. O. , ERCAN S., ORCUN A., SEKER M., Salepçi T., et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.68, no.2, pp.309-316, 2011 (Peer-Reviewed Journal)
2011
2011Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast
Seker M., BILICI A., USTAALIOGLU B. O. , YILMAZ B., Ozturk B., ÜNAL A., et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.284, no.2, pp.405-409, 2011 (Peer-Reviewed Journal)
2011
2011Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey
Basaran G., Turhal N. S. , Cabuk D., Yurt N., Yurtseven G., Gumus M., et al.
MEDICAL ONCOLOGY, vol.28, no.2, pp.409-415, 2011 (Peer-Reviewed Journal)
2011
2011Co-existence of Gastrointestinal Stromal Tumors with Other Primary Neoplasms
Sevinc A., SEKER M., BILICI A., OZDEMIR N. Y. , Yildiz R., USTAALIOGLU B. O. , et al.
HEPATO-GASTROENTEROLOGY, vol.58, no.107, pp.824-830, 2011 (Peer-Reviewed Journal)
2011
2011Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients with breast cancer?
SONMEZ B., SEKER M., BILICI A., ERKAL F. Y. , USTAALIOGLU B. B. O. , Gumus M., et al.
JOURNAL OF BUON, vol.16, no.2, pp.227-232, 2011 (Peer-Reviewed Journal)
2011
2011Efficacy, safety and prognostic features of resected colon carcinoma treated in "real world" practice: a retrospective cohort-study
DANE F., OZTURK M. A. , Gumus M., GUVEN A., ALIUSTAOGLU M., CABUK D., et al.
JOURNAL OF BUON, vol.16, no.2, pp.257-264, 2011 (Peer-Reviewed Journal)
2011
2011A retrospective analysis of women's chances to become pregnant after completion of chemotherapy: a single center experience
USTAALIOGLU B. B. O. , BILICI A., KEFELI U., SEKER M., SALEPCI T., UNAL O., et al.
JOURNAL OF BUON, vol.16, no.2, pp.349-352, 2011 (Peer-Reviewed Journal)
2011
2011Pulmonary BALT Lymphoma Successfully Treated with Eight Cycles Weekly Rituximab: Report of First Case and F-18 FDG PET/CT Images
BILICI A., SEKER M., USTAALIOGLU B. B. O. , CANPOLAT N., Salepçi T., Gumus M.
JOURNAL OF KOREAN MEDICAL SCIENCE, vol.26, no.4, pp.574-576, 2011 (Peer-Reviewed Journal)
2011
2011The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma
USTAALIOGLU B. B. O. , SEKER M., BILICI A., CANPOLAT N., YILDIRIM E., KEFELI U., et al.
MEDICAL ONCOLOGY, vol.28, no.1, pp.258-264, 2011 (Peer-Reviewed Journal)
2011
2011A case of metastatic breast cancer successfully treated with lapatinib plus capecitabine therapy
KEFELI U., BILICI A., USTAALIOGLU B. B. O. , Kefeli A. U. , YILDIRIM M. E. , SEKER M., et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.283, no.2, pp.405-407, 2011 (Peer-Reviewed Journal)
2011
2011Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure
ALKIS N., Demirci U., Benekli M., Yilmaz U., Isikdogan A., Sevinc A., et al.
JOURNAL OF BUON, vol.16, no.1, pp.80-83, 2011 (Peer-Reviewed Journal)
2011
2011The role of F-18-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?
BILICI A., USTAALIOGLU B. B. O. , SEKER M., KEFELI U., CANPOLAT N., TEKINSOY B., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.38, no.1, pp.64-73, 2011 (Peer-Reviewed Journal)
2011
2011DETERMINATION OF PARAMETERS AFFECTING THE USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE IN CANCER PATIENTS AND DETECTION OF PREVALENCE OF USE
MAYADAGLI A., AKSU A., GOKSEL F., GOCEN E., Karahacioglu E., Gumus M., et al.
AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES, vol.8, no.4, pp.477-482, 2011 (Peer-Reviewed Journal)
2010
2010Pulmonary toxicity in patients receiving docetaxel chemotherapy
YUMUK P. F. , KEFELI U., CEYHAN B., DANE F., EROGLU B. T. , Gumus M., et al.
MEDICAL ONCOLOGY, vol.27, no.4, pp.1381-1388, 2010 (Peer-Reviewed Journal)
2010
2010The association of serum adiponectin levels with histopathological variables in gastric cancer patients
SEKER M., BILICI A., SONMEZ B., USTAALIOGLU B. B. O. , GUMUS M., Gözü H., et al.
MEDICAL ONCOLOGY, vol.27, no.4, pp.1319-1323, 2010 (Peer-Reviewed Journal)
2010
2010The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment
ALIUSTAOGLU M., BILICI A., USTAALIOGLU B. B. O. , KONYA V., GUCUN M., SEKER M., et al.
MEDICAL ONCOLOGY, vol.27, no.4, pp.1060-1065, 2010 (Peer-Reviewed Journal)
2010
2010Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience
BILICI A., Salepçi T., DANE F., Gumus M., USTAALIOGLU B. B. O. , SEKER M., et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.282, no.4, pp.417-425, 2010 (Peer-Reviewed Journal)
2010
2010Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer
BILICI A., SEKER M., USTAALIOGLU B. B. O. , YILMAZ B., DOVENTAS A., Salepçi T., et al.
MEDICAL ONCOLOGY, vol.27, no.3, pp.975-984, 2010 (Peer-Reviewed Journal)
2010
2010Docetaxel combined with oral etoposide as second-line treatment for advanced gastric carcinoma after failure of platinum- and fluoropyrimidine-based regimens.
YILDIZ R., KALENDER M., DANE F., SEVINC A., Gumus M., CAMCI C., et al.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, vol.16, pp.173-8, 2010 (Peer-Reviewed Journal)
2010
2010Prognostic Significance of Perineural Invasion in Patients with Gastric Cancer Who Underwent Curative Resection
BILICI A., SEKER M., USTAALIOGLU B. B. O. , KEFELI U., YILDIRIM E., YAVUZER D., et al.
ANNALS OF SURGICAL ONCOLOGY, vol.17, no.8, pp.2037-2044, 2010 (Peer-Reviewed Journal)
2010
2010Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma
SEKER M., USTAALIOGLU B. B. O. , BILICI A., YILDIRIM M. E. , KEFELI U., BARISIK N. O. , et al.
LEUKEMIA RESEARCH, vol.34, no.7, 2010 (Peer-Reviewed Journal)
2010
2010Is there a cut-off value for standardized uptake values in positron emission tomography for predicting response to treatment and survival in patients with advanced non-small cell lung cancer? Single center experience
USTAALIOGLU B. B. O. , Gumus M., BILICI A., SEKER M., USTAALIOGLU R., KEFELI U., et al.
JOURNAL OF BUON, vol.15, no.3, pp.529-536, 2010 (Peer-Reviewed Journal)
2010
2010Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?
BILICI A., USTAALIOGLU B. B. O. , SEKER M., CANPOLAT N., TEKINSOY B., Salepçi T., et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.37, no.7, pp.1259-1269, 2010 (Peer-Reviewed Journal)
2010
2010Malignancies Diagnosed During Pregnancy and Treated With Chemotherapy or Other Modalities (Review of 27 Cases) Multicenter Experiences
USTAALIOGLU B. B. O. , Gumus M., ÜNAL A., Cayir K., Sever O., BILICI A., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol.20, no.5, pp.698-703, 2010 (Peer-Reviewed Journal)
2010
20105-Fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels
Salepçi T., SEKER M., UYAREL H., Gumus M., BILICI A., USTAALIOGLU B. B. O. , et al.
MEDICAL ONCOLOGY, vol.27, no.2, pp.416-420, 2010 (Peer-Reviewed Journal)
2010
2010Preoperative serum leptin levels in patients with breast cancer
ALIUSTAOGLU M., BILICI A., Gumus M., COLAK A. T. , BALOGLU G., IRMAK R., et al.
MEDICAL ONCOLOGY, vol.27, no.2, pp.388-391, 2010 (Peer-Reviewed Journal)
2010
2010Neoadjuvant chemotherapy for locally advanced breast cancer: a single center experience
USTAALIOGLU B. B. O. , Gumus M., BILICI A., SEKER M., DANE F., Salepçi T., et al.
MEDICAL ONCOLOGY, vol.27, no.2, pp.454-458, 2010 (Peer-Reviewed Journal)
2010
2010The Association of Pre-treatment Peripheral Blood Markers with Survival in Patients with Pancreatic Cancer
ALIUSTAOGLU M., BILICI A., SEKER M., DANE F., GOCUN M., KONYA V., et al.
HEPATO-GASTROENTEROLOGY, vol.57, pp.640-645, 2010 (Peer-Reviewed Journal)
2010
2010Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer
Kaya A. O. , Buyukberber S., DANE F., Isikdogan A., USTAALIOGLU B. O. , Coskun U., et al.
TUMORI J, vol.96, no.3, pp.400-404, 2010 (Peer-Reviewed Journal)
2010
2010Endometrial Adenocarcinoma Metastasis to Nasal Skin
SEZEN O. S. , ERASLAN G., COSKUNER T., YAVUZER D., BILICI A., BILGE S., et al.
JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, vol.39, no.2, 2010 (Peer-Reviewed Journal)
2010
2010Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: Positron emission tomography images before and after therapy: A case report
USTAALIOGLU B. B. O. , BILICI A., SEKER M., CANPOLAT N., OZDEMIR N., Salepçi T., et al.
LEUKEMIA RESEARCH, vol.34, no.4, 2010 (Peer-Reviewed Journal)
2010
2010Expression and prognostic significance of cox-2 and p-53 in hodgkin lymphomas: a retrospective study
BARISIK N. O. , BOZKURT S., Gumus M., Kaygusuz I., KARADAYI N., Bas E., et al.
DIAGNOSTIC PATHOLOGY, vol.5, 2010 (Peer-Reviewed Journal)
2010
2010F-18 FDG PET/CT imaging in recurrent mantle cell lymphoma presenting with cauda equina syndrome
Bilici A., Ustaalioglu B. B. O. , Seker M., Canpolat N., Gumus M.
Clinical Nuclear Medicine, vol.35, no.3, pp.211-212, 2010 (Peer-Reviewed Journal)
2010
2010Lung cancer presenting with extreme leukocytosis
SALMAN T., SEKER M., BILICI A., USTAALIOGLU B. B. , Gumus M., YAYLACI M.
JOURNAL OF BUON, vol.15, no.1, pp.193, 2010 (Peer-Reviewed Journal)
2010
2010Does the Metastatic Lymph Node Ratio Influence the Disease-Free Survival of Patients with Breast Cancer: Single-Center Experiences
USTAALIOGLU B. B. O. , BILICI A., KEFELI U., SEKER M., YILDIRIM E., Salepçi T., et al.
ONCOLOGY, vol.79, pp.105-111, 2010 (Peer-Reviewed Journal)
2010
2010The Effect of Tumor Size on Overall Survival in Patients with pT3 Gastric Cancer: Experiences from 3 Centers
BILICI A., UYGUN K., SEKER M., USTAALIOGLU B. B. O. , ALIUSTAOGLU M., Temiz S., et al.
ONKOLOGIE, vol.33, no.12, pp.676-682, 2010 (Peer-Reviewed Journal)
2010
2010Bilateral Conjunctival MALT Lymphoma Mimicking Chronic Conjunctivitis
SEKER M., OZDEMIR B., BILICI A., USTAALIOGLU B. B. , SÖNMEZ B., YILMAZ B. E. , et al.
ONKOLOGIE, vol.33, no.6, pp.317-320, 2010 (Peer-Reviewed Journal)
2010
2010Factors that Affect Patients' Decision-Making about Mastectomy or Breast Conserving Surgery, and the Psychological Effect of this Choice on Breast Cancer Patients
Gumus M., USTAALIOGLU B. O. , GARIP M., KIZILTAN E., BILICI A., SEKER M., et al.
BREAST CARE, vol.5, no.3, pp.164-168, 2010 (Peer-Reviewed Journal)
2010
2010CD8+CD28-cells and CD4+CD25+regulatory T cells in the peripheral blood of advanced stage lung cancer patients
KARAGOZ B., BILGI O., Gumus M., ERIKCI A. A. , SAYAN O., TURKEN O., et al.
MEDICAL ONCOLOGY, vol.27, no.1, pp.29-33, 2010 (Peer-Reviewed Journal)
2010
2010Is Metastatic Lymph Node Ratio Superior to the Number of Metastatic Lymph Nodes to Assess Outcome and Survival of Gastric Cancer?
BILICI A., USTAALIOGLU B. B. O. , Gumus M., SEKER M., YILMAZ B., KEFELI U., et al.
ONKOLOGIE, vol.33, no.3, pp.101-105, 2010 (Peer-Reviewed Journal)
2009
2009Acute renal failure and multiple extranodal involvement in a patient with diffuse large B cell lymphoma
SEKER M., USTAALIOGLU B., BILICI A., OZSEKER N., AKSU A., Gumus M.
Journal of B.U.ON., vol.14, no.4, pp.726-727, 2009 (Peer-Reviewed Journal)
2009
2009Renal cell carcinoma with pulmonary metastasis misdiagnosed as other primary malignant tumor
OVEN B. B. U. , BILICI A., SEKER M., SALEPCI T., KESER S., Gumus M.
JOURNAL OF BUON, vol.14, no.4, pp.727-728, 2009 (Peer-Reviewed Journal)
2009
2009Anthracycline-induced subclinical right ventricular dysfunction in adults
USTAOGLU M. A. , DUMAN D., GUCUN M., KONYA V., DANE F., Gumus M.
EUROPEAN HEART JOURNAL, vol.30, pp.569, 2009 (Peer-Reviewed Journal)
2009
2009Nose skin metastasis of uterine endometrial adenocarcinoma: case report
HALLAC K. S. , YAVUZER D., ERGEN C., EGE G. A. , OZDEMIR B. N. , CAKIR C., et al.
VIRCHOWS ARCHIV, vol.455, pp.298, 2009 (Peer-Reviewed Journal)
2009
2009Conjunctival malt lymphoma successfully treated with single agent rituximab therapy
SALEPCI T., Seker M., Kurnaz E., GULER D., BILICI A., DANE F., et al.
LEUKEMIA RESEARCH, vol.33, no.3, pp.1, 2009 (Peer-Reviewed Journal)
2009
2009Metastasis of Lobular Breast Carcinoma to the Uterus in a Patient under Anastrozole Therapy
USTAALIOGLU B. B. O. , BILICI A., SEKER M., SALMAN T., Gumus M., BARISIK N. O. , et al.
ONKOLOGIE, vol.32, no.7, pp.424-426, 2009 (Peer-Reviewed Journal)
2009
2009Induction chemotherapy and chemoradiation therapy for inoperable locally advanced non-small-cell lung cancer: A single-institution review of two different regimens
Kocak M., Ozkan A., Mayadagli A., Parlak C., Bilici A., Seker M., et al.
Clinical Lung Cancer, vol.10, no.2, pp.124-129, 2009 (Peer-Reviewed Journal)
2009
2009Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas
ALICI S., Coskun U., Alkış N., Sevinc A., DANE F., Gumus M., et al.
Asian Pacific Journal of Cancer Prevention, vol.10, no.6, pp.1051-1056, 2009 (Peer-Reviewed Journal)
2009
2009Efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer
Karaoglu A., ARSLAN U. Y. , ÖZKAN M., Kalender M. E. , ALICI S., Coskun U., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.10, no.1, pp.63-66, 2009 (Peer-Reviewed Journal)
2008
2008The relation of COX-2 expression with other prognostic parameters in invasive ductal carcinomas
BARISIK N. O. , KESER S., GUEL A., CAYIRCI M., KARADAYI N., Guemues M., et al.
VIRCHOWS ARCHIV, vol.452, 2008 (Peer-Reviewed Journal)
2008
2008Peripheral blood gamma-delta T cells in advanced-stage cancer patients
BILGI O., KARAGOZ B., TURKEN O., KANDEMIR E. G. , OZTURK A., Gumus M., et al.
ADVANCES IN THERAPY, vol.25, no.3, pp.218-224, 2008 (Peer-Reviewed Journal)
2008
2008Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer
KOLDAS M., Gumus M., SEKER M., SEVAL H., KARAOGLU H., DANE F., et al.
CLINICAL LUNG CANCER, vol.9, no.2, pp.112-115, 2008 (Peer-Reviewed Journal)
2008
2008Whole Body 18F-FDG PET/CT Imaging in the Detection of Primary Tumours in Patients with a Metastatic Carcinoma of Unknown Origin
Kaya A. O. , Coskun U., Unlu M., Akdemir U. O. , Ozdemir N. Y. , Zengin N., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.9, no.4, pp.683-686, 2008 (Peer-Reviewed Journal)
2007
2007Outcome of metastatic non-small cell lung carcinoma patients receiving docetaxel-cisplatin combination chemotherapy: single institution experience
KOCAK M., MAYADAGLI A., OZKAN A., PARLAK C., DEMIR O., MARTI A., et al.
JOURNAL OF BUON, vol.12, no.4, pp.471-476, 2007 (Peer-Reviewed Journal)
2007
2007Expression and prognostic significance of COX-2 and p 53 in Hodgkin lymphomas
Barisik N., Bozkurt S., Gumus M., Kaygusuz I., Karadayi N., Bas E., et al.
VIRCHOWS ARCHIV, vol.451, no.2, pp.442, 2007 (Peer-Reviewed Journal)
2007
2007Expression and prognostic significance of survivin and p 53 in Hodgkin lymphomas
Bozkurt S., Barisik N., Kaygusuz I., Gumus M., Bas E., Gezer S., et al.
VIRCHOWS ARCHIV, vol.451, no.2, pp.442, 2007 (Peer-Reviewed Journal)
2007
2007Cyclooxygenase expression in the colon adenocarcinomas and its relationship with other prognostic parameters
BILGIC M., BARIŞIK N. O. , MURTAZAOGLU M., GEZGIN S., KARADAYI N., KESER S., et al.
VIRCHOWS ARCHIV, vol.451, no.2, pp.324, 2007 (Peer-Reviewed Journal)
2007
2007XELOX followed by XELIRI or the reverse sequence in advanced colorectal cancer
Sakar B., Gumus M., Başaran M., ARGON A., Ustuner Z., USTAOGLU M. A. , et al.
ONCOLOGY, vol.73, pp.298-304, 2007 (Peer-Reviewed Journal)
2006
2006HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples
Gumus M., YUMUK P. F. , SALEPCI T., ALIUSTAOGLU M., DANE F., EKENEL M., et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, vol.25, no.4, pp.515-521, 2006 (Peer-Reviewed Journal)
2005
2005What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery?
Gumus M., YUMUK P., ATALAY G., ALIUSTAOGLU M., MACUNLUOGLU B., DANE F., et al.
TUMORI J, vol.91, no.2, pp.168-172, 2005 (Peer-Reviewed Journal)
2005
2005Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer
YUMUK P., TURHAL N., Gumus M., HATABAY N., TURKEN O., OZKAN A., et al.
BMC CANCER, vol.5, 2005 (Peer-Reviewed Journal)
2005
2005Does the incidence of anal canal cancers differ in Moslem societies?
YUMUK P., ABACIOGLU U., DEMIR G., CABUK D., DANE F., Gumus M., et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, vol.20, no.1, pp.76, 2005 (Peer-Reviewed Journal)
2004
2004D-dimer - Can it be a marker for malignant gastric lesions?
ALIUSTAOGLU M., YUMUK P., Gumus M., EKENEL M., BOLUKBAS F., BOLUKBAS C., et al.
ACTA ONCOLOGICA, vol.43, no.8, pp.770-771, 2004 (Peer-Reviewed Journal)
2004
2004The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients
YUMUK P., AYDIN S., DANE F., Gumus M., EKENEL M., ALIUSTAOGLU M., et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, vol.19, no.6, pp.609-610, 2004 (Peer-Reviewed Journal)
2004
2004Child-Pugh classification dependent alterations in serum leptin levels among cirrhotic patients: a case controlled study
BOLUKBAS F., BOLUKBAS C., HOROZ M., Gumus M., ERDOGAN M. S. , ZEYREK F., et al.
BMC GASTROENTEROLOGY, vol.4, 2004 (Peer-Reviewed Journal)
2004
2004Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study
BOLUKBAS F., KILIC H., BOLUKBAS C., Gumus M., HOROZ M., TURHAL N., et al.
BMC CANCER, vol.4, 2004 (Peer-Reviewed Journal)
2004
2004Attitude toward genetic testing for cancer risk in Istanbul
YUMUK P., Gumus M., EKENEL M., BASARAN G., ALIUSTAOGLU M., TOPAL A., et al.
GENETIC TESTING, vol.8, no.2, pp.169-173, 2004 (Peer-Reviewed Journal)
2004
200499m-Tc-MDP-scintimammography in the evaluation of breast masses or tumor angiogenesis
TURHAL N., DANE F., DEDE F., Gumus M., YUMUK P., CAKALAGAOGLU F., et al.
ANTICANCER RESEARCH, vol.24, pp.1999-2006, 2004 (Peer-Reviewed Journal)
2004
2004Timing of death from tumor recurrence after curative gastrectomy for gastric cancer
SAKAR B., KARAGOL H., Gumus M., BASARAN M., KAYTAN E., ARGON A., et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.27, no.2, pp.205-209, 2004 (Peer-Reviewed Journal)
2003
2003Outcome of rectal and sigmoid carcinoma patients receiving adjuvant chemoradiotherapy in marmara university hospital
YUMUK P., ABACIOGLU U., CAGLAR H., Gumus M., SENGOZ M., TURHAL N.
JOURNAL OF CHEMOTHERAPY, vol.15, no.6, pp.603-606, 2003 (Peer-Reviewed Journal)
2003
2003Status epilepticus in a case of Wilson's disease during D-pencillamine treatment
TURK-BORU U., KOCER A., ALP R., Gumus M., Gumus M.
SWISS MEDICAL WEEKLY, vol.133, pp.446-447, 2003 (Peer-Reviewed Journal)
2003
2003Neoplastic diseases prevalence in a turkish university hospital
Turhal N., Aliustaoglu M., Gurses A., Gumus M., Atalay G., Karamanoglu A., et al.
Journal of B.U.ON., vol.8, no.1, pp.45-48, 2003 (Peer-Reviewed Journal)
2002
2002Patient satisfaction in the outpatients' chemotherapy unit of Marmara University, Istanbul, Turkey: a staff survey.
TURHAL N., EFE B., Gumus M., ALIUSTAOGLU M., KARAMANOGLU A., SENGOZ M.
BMC cancer, vol.2, pp.30, 2002 (Peer-Reviewed Journal)
2002
2002Outpatient cancer care in a Turkish University hospital
TURHAL N., Gumus M., ATALAY G., ALIUSTAOGLU M., KABAKAS F., KARAMANOGLU A., et al.
Journal of B.U.ON., vol.7, no.4, pp.397-398, 2002 (Peer-Reviewed Journal)
2002
2002Port needles need not to be removed as frequently in infusional cancer chemotherapy, our experience in a University Hospital in Istanbul, Turkey
Karamanoglu A., Fulden Yumuk P., Gumus M., Aliustaoglu M., Selimen D., Sengoz M., et al.
BONE MARROW TRANSPLANTATION, vol.29, 2002 (Peer-Reviewed Journal)
2002
2002Predictive factors associated with axillary lymph node metastasis(ALNM) in T1, T2 and T3 breast carcinomas
Atalay G., Gumus M., Aliustaoglu M., Turhal N.
EUROPEAN JOURNAL OF CANCER, vol.38, 2002 (Peer-Reviewed Journal)
Articles Published in Other Journals
2022
2022Is docetaxel-free interval a predictive factor for castration-resistant prostate cancer?
Ay S., Efiloğlu Ö., Tataroğlu Özyükseler D., Dülgar Ö., Mutlu Günaydın U., Yıldırım A., et al.
Actas urologicas espanolas, vol.46, no.9, pp.550-556, 2022 (Peer-Reviewed Journal)
2021
2021Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study.
Atcı M. M. , Geredeli Ç., Ay S., Sakin A., Ertürk B., Seçmeler Ş., et al.
European journal of breast health, vol.17, pp.123-127, 2021 (Peer-Reviewed Journal)
2020
2020Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer
Ercelep O., Tataroglu D., Ozcelik M., Surmeli H., Degirmenci M., Inanc M., et al.
TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol.17, no.2, pp.123-127, 2020 (Peer-Reviewed Journal)
2016
2016Turkish Ministry of Health, 2nd Turkish Medical General Assembly Clinical Oncology Study Group Report
Ozmen V., Dagoglu N., DEDE I., AKCAKAYA A., Kerem M., GOKSEL F., et al.
JOURNAL OF BREAST HEALTH, vol.12, no.1, pp.9-17, 2016 (Peer-Reviewed Journal)
2014
2014Non-Small Cell Lung Cancer in Women: A Distinct Entity?
KEFELI U., USTAALIOGLU B. B. O. , YILMAZ B., AYDIN D., SENER N., ALIUSTAOGLU M., et al.
Gazi Medical Journal, vol.25, no.3, pp.92-96, 2014 (Peer-Reviewed Journal)
2014
2014Akciğer Kanserli Geriatrik Hastalarda Tedavi Yaklaşımı Treatment Approach for Lung Cancer of Geriatric Patients
GÜL Ş. K. , MAYADAĞLI A., GÜMÜŞ M.
J Kartal TR, vol.25, no.3, pp.257-260, 2014 (Peer-Reviewed Journal)
2013
2013İleri Evre Gastroenteropankreatik Nöroendokrin Tümörlerin Tedavisinde Sunitinib'in Yeri
AYDIN K., GÜMÜŞ M.
Turkiye Klinikleri Journal of Medical Oncology Special Topics, vol.6, no.2, pp.57-60, 2013 (Peer-Reviewed Journal)
2012
2012The Relationship between Prognostic Factors and Overall Survival in Small Cell Lung Cancer Patients: a Single Centre Experience
USTAALIOGLU B. B. O. , BILICI A., SEKER M., SALEPCI T., USTAALİOĞLU R., CÖMERT S., et al.
Türk Toraks Dergisi, vol.13, pp.60-64, 2012 (Peer-Reviewed Journal)
2012
2012Sarcomatoid carcinoma of the small intestine: a case report and review of the literature
Ekici K., MAYADAGLI A., KORKMAZ T., BARISIK N., GÜMÜŞ M.
Case Study and Case Report, vol.2, no.3, pp.74-80, 2012 (Peer-Reviewed Journal)
2012
2012Epidemiology and Etiology in Gastric Cancer
GÜMÜŞ M.
Turkiye Klinikleri Journal of Medical Oncology Special Topics Issue, vol.5, no.3, pp.1-5, 2012 (Peer-Reviewed Journal)
2012
2012Clinicopathological features in patients with rare ovarian cancers
BILICI A., USTAALIOGLU B. B. O. , SEKER M., GÜMÜŞ M., Ünal O.
TÜRK ONKOLOJİ DERGİSİ, vol.27, no.1, pp.1-9, 2012 (Peer-Reviewed Journal)
2012
2012Memenin Primer Skuamöz Hücreli Karsinomu: Olgu Sunumu ve Literatürün Gözden Geçirilmesi
MAYADAĞLI A., Ekici K., Kökten Ş., GÜMÜŞ M.
OKMEYDANİ TİP DERGİSİ, vol.28, no.2, pp.112-114, 2012 (Peer-Reviewed Journal)
2011
2011GÖĞÜS DUVARINA METASTAZ YAPAN VE CERRAHİ UYGULANAN RENAL PELVİS KARSİNOMA OLGUSU
USTAALİOĞLU B. B. , USTAALİOĞLU R., BİLİCİ A., DOĞUSOY I., BARIŞIK N. Ö. , GÜMÜŞ M.
ACTA ONCOLOGİCA TURCİCA, vol.44, no.1, pp.36-41, 2011 (Peer-Reviewed Journal)
2011
2011Evaluation of Hodgkin lymphoma cases and determination of prognostic factors/Hodgkin lenfoma olgularinin retrospektif degerlendirilmesive prognostik faktorlerin saptanmasi
ŞEKER M., MENGİ A., BİLİCİ A., USTAALİOĞLU B. B. , KEFELİ U., ÖZŞEKER N. I. , et al.
Turkish Journal of Oncology, vol.26, no.3, pp.108-114, 2011 (Peer-Reviewed Journal)
2010
2010Lenf Nodu Negatif Mide Kanserli Hastalarda Sağkalım Üzerine EtkiliPrognostik Faktörlerin Değerlendirilmesi: Üç Merkez Deneyimi
BİLİCİ A., SEKER M., USTAALIOGLU B. B. O. , DANE F., ALIUSTAOGLU M., ERKOL B., et al.
TÜRK ONKOLOJİ DERGİSİ, vol.25, no.4, pp.135-142, 2010 (Peer-Reviewed Journal)
2010
2010Antijen Temelli Aşılar
GÜMÜŞ M.
Turkiye Klinikleri J Med Oncol-Special Topics, vol.3, no.2, pp.77-82, 2010 (Peer-Reviewed Journal)
2010
2010Kapesitabin: Kolorektal Kanserlerde Kullanımı
BILICI A., GÜMÜŞ M.
Remisyon, vol.10, no.1, pp.11-16, 2010 (Peer-Reviewed Journal)
2010
2010A Case of Recurrent Breast Cancer Diagnosed vvith Isolated Ovarian Metastasis Under Anastrazole Therapy
BILICI A., SEKER M., USTAALIOGLU B. B. O. , SALMAN T., SALEPCI T., YAVUZER D., et al.
ACTA ONCOLOGİCA TURCİCA, vol.43, pp.42-45, 2010 (Peer-Reviewed Journal)
2010
2010Is the Complete Blood Count Parameters Predict Prognosis Before Treatment in Metastatic Gastric Cancer Patients?
ALIUSTAOGLU M., USTAALIOGLU B. B. O. , BILICI A., Konya V., Gücün M., SEKER M., et al.
ACTA ONCOLOGİCA TURCİCA, vol.43, no.1, pp.13-18, 2010 (Peer-Reviewed Journal)
2009
2009İnflamatuvar Meme Kanseri Serimiz: Tek Merkez Deneyimi
USTAALIOGLU B. B. O. , BILICI A., SEKER M., SALEPCI T., YILDIRIM E., KEFELI U., et al.
ACTA ONCOLOGİCA TURCİCA, vol.42, no.3, pp.93-99, 2009 (Peer-Reviewed Journal)
2008
2008NADİR BİR NAZOLAKRİMAL HEMANJİYOPERİSTOM OLGUSU
USTAALIOGLU B., SEKER M., BILICI A., ERKOL B., KEFELI U., YILDIRIM E., et al.
KARTAL EĞİTİM VE ARAŞTIRMA HASTANESİ TIP DERGİSİ, vol.19, no.2, pp.93-96, 2008 (Peer-Reviewed Journal)
2007
2007Mediastinal Dev Schwannoma
DEMİRHAN R., ÖZ K., ÇAĞAN P., DABAK R., MAYADAĞLI A., GÜMÜŞ M.
Akciğer, vol.13, no.2, pp.95-98, 2007 (Peer-Reviewed Journal)
2006
2006AKCİĞER KANSERLERİNDE REZEKSİYON SONUÇLARIMIZ: ARDIŞIK 45 HASTANIN DEĞERLENDİRİLMESİ
DEMİRHAN R., MAYADAĞLI A., SANCAKLI İ., ÖZDEMİR N., GÜMÜŞ M., PARLAK C., et al.
Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, vol.17, no.2, pp.82-88, 2006 (Peer-Reviewed Journal)
2004
2004HODGKiN DIŞI LENFOMALI HASTALARıN KLiNiK ÖZELLiKLERiNiN VE TEDAVi SONUÇLARININ DEGERLENDiRiLMESi
KARAOĞLU H., GÜMÜŞ M., SARGIN H., KOÇ Y., GÜLER Ş., COLAK A. T. , et al.
KARTAL EĞİTİM VE ARAŞTIRMA HASTANESİ TIP DERGİSİ, vol.15, no.1, pp.8-10, 2004 (Peer-Reviewed Journal)
2004
2004Lokal ‹leri ve Metastatik Küçük Hücreli D›fl› Akci¤er Kanseri Hastalar›n›n De¤erlendirilmesi Marmara Üniversitesi Deneyimi
YUMUK F., İYİKESİCİ S., GÜMÜŞ M., ALIUSTAOGLU M., DANE F., BASARAN G., et al.
TÜRK ONKOLOJİ DERGİSİ, vol.19, no.3, pp.106-111, 2004 (Peer-Reviewed Journal)
2004
2004Evre I (T1N0M0) Meme Kanseri: Patolojik Özellikler ve Klinik Sonuçlar
BASARAN G., EKENEL M., Demirkalem P., Çakır T., Güllüoğlu B., GÜMÜŞ M., et al.
TÜRK ONKOLOJİ DERGİSİ, vol.19, no.2, pp.53-57, 2004 (Peer-Reviewed Journal)
2003
2003AKUT MYOKARD İNFARKTÜSÜ GEÇİREN ERKEK HASTALARDA SERUM ÖSTRADİOL, TESTOSTERON VE NOREPİNEFRİN DÜZEYLERİ
RAMAZANOĞLU D. T. , GÜMÜŞ M., KOÇ Y., ŞEKER M., SARGIN H., TEKÇE M., et al.
KARTAL EĞİTİM VE ARAŞTIRMA HASTANESİ TIP DERGİSİ, vol.14, no.3, pp.159-163, 2003 (Peer-Reviewed Journal)
2003
2003PANKREAS KARS‹NOMLU OLGULARIN DE⁄ERLEND‹R‹LMES‹
KOÇ Y., SARGIN H., GEMİCİ C., BOLUKBAS F., GÜMÜŞ M., TEKÇE M., et al.
Kartal E¤itim ve Araflt›rma Hastanesi T›p Dergisi, vol.14, no.3, pp.146-148, 2003 (Peer-Reviewed Journal)
2003
2003Port Needles: Do They Need to be Removed as Frequently in Infusional Chemotherapy?
Karamanoglu A., YUMUK P. F. , Gumus M., EKENEL M., ALIUSTAOGLU M., SELIMEN D., et al.
Journal of Infusion Nursing, vol.26, no.4, pp.239-242, 2003 (Peer-Reviewed Journal)
2003
2003İmidazolin Reseptör Agonisti Rilmenidinin, Metabolik Sendrom X Olgularında Klinik, Metabolik ve Endokrin Parametrelere Etkisi.
Yıldız G., SARGIN M., SARGIN H., GÜMÜŞ M., YAYLA A.
Diabet Bilimi, vol.1, no.2, pp.71-76, 2003 (Peer-Reviewed Journal)
2003
2003MALİGN MEZOTELYOMA VAKALARINDA YÜKSEK DOZ METOTREKSAT UYGULAMASININ ETKİNLİĞİ
SEVER Ö. N. , GÜMÜŞ M., SARGIN H., KOÇ Y., SALEPÇİ T., YAYLA A.
Kartal E¤itim ve Araflt›rma Hastanesi T›p Dergisi, vol.14, no.1, pp.20-22, 2003 (Peer-Reviewed Journal)
2002
2002Akut Myokard İnfarktüsünde Mikroalbuminüri ve Trombolitik Tedavinin Mikroalbuminüri Düzeylerine Etkisi
ERBAY İ., GÜMÜŞ M., SARGIN H., FENERCİOĞLU S., SARGIN M., SEKER M., et al.
ŞİŞLİ ETFAL HASTANESİ TIP BÜLTENİ, vol.36, no.3, pp.43-48, 2002 (Peer-Reviewed Journal)
2001
2001DiYABETiK HASTALARDA KARACiGER YAGLANMASI VE y-GLUTAMiL TRANSPEPTiDAZ DÜZEYLERi
BİRİZ N., GÜMÜŞ M., Sargın M., Emre B., KOÇ Y., ALIUSTAOGLU M., et al.
Kartal Eğitim ve Araştırma Tıp Dergisi, vol.12, pp.1-4, 2001 (Peer-Reviewed Journal)
2001
2001Ağrılı Diabetik Polinöropatide Vigabatrine Kullanımı
TÜRK Ü. B. , SARGIN H., ALP R., SARGIN M., GÜMÜŞ M., TEKÇE M., et al.
ANKARA EĞİTİM VE ARAŞTIRMA HASTANESİ TIP DERGİSİ, vol.34, pp.8-12, 2001 (Peer-Reviewed Journal)
2000
2000AKUT MYOKARD İNFARKTÜSÜNDE AKUT FAZ REAKTANLARINDAKİ DEGİşİM VE TROMBOLİTİK TEDAVİNİN BU DEGİşİME ETKİsİ
FENERCİOĞLU S., GÜMÜŞ M., ERBAY İ., SARGIN H., SARGIN M., ALIUSTAOGLU M., et al.
KARTAL EĞİTİM VE ARAŞTIRMA HASTANESİ TIP DERGİSİ, vol.11, no.3, pp.865-869, 2000 (Peer-Reviewed Journal)
2000
2000Diyabet Süresi, HbA1c Düzeyleri ve Retinopati
GÜMÜŞ M., URUTÜRK O., SARGIN M., AKIN A., KOÇ Y., ALİUSTAOĞLU M., et al.
KARTAL EĞİTİM VE ARAŞTIRMA HASTANESİ TIP DERGİSİ, vol.11, no.3, pp.862-864, 2000 (Peer-Reviewed Journal)
2000
2000ANTİHİPERTANSİF TEDAVİDE DOKSAZOsİN, AMLODİpİN VE RAMİpRiLİN KAN LİPID PROFİLİ VE KAN GLUKOZ DÜZEYİNE ETKİLERİNİN KARŞILAŞTIRILMASI
KOÇ Y., GÜMÜŞ M., SARGIN M., KAVAKLI B., YAYLA A.
KARTAL EĞİTİM VE ARAŞTIRMA HASTANESİ TIP DERGİSİ, vol.11, pp.817-819, 2000 (Peer-Reviewed Journal)
2000
2000Boğaz kültürlerinde üretilen beta hemolitik streptokoklar ve antibiyotiklere duyarlılıkları
SAMASTI M., Er E., Akdoğan M., Köksal F., Gümüş M., Özdemir A.
İnfeksiyon Derg, vol.14, no.4, pp.519-521, 2000 (Peer-Reviewed Journal)
1999
1999KRONİK BÖBREK YETMEZLİGİNDE HEMODİYALİZİN ATRİAL NATRİüRETİK PEPTİD DÜZEYLERİNE ETKİsİ
ALİUSTAOĞLU M., GÜMÜŞ M., GÖKÇEL A., ÖZER T., BİCAN M., ÖZDİL K., et al.
KARTAL EĞİTİM VE ARAŞTIRMA HASTANESİ TIP DERGİSİ, vol.10, pp.740-742, 1999 (Peer-Reviewed Journal)
1999
1999ANJİOTENSİN II RESEPTÖR BLOKAJININ Tİp II DİABETES MELLİTUS'LU HASTALARDA KAN LİpİD DÜZEYLERİNE ETKİSi'
GÜMÜŞ M., Kavaklı B., AKTAŞ S., SARĞIN M., ALIUSTAOGLU M., ÖZDİL K., et al.
KARTAL EĞİTİM ve ARAŞTIRMA KLİNİKLERİ, vol.10, pp.752-757, 1999 (Peer-Reviewed Journal)
1998
1998DiABETES MELLiTUS'UN AKUT METABOLiK KOMPLiKASYONLARI - II: HiPERGLiSEMiK HiPEROZMOLAR NONKETOTiK KOMA
KAVAKLI B., SARGIN M., GÜMÜŞ M.
Kartal Eğitim Araştırma Klinikleri, vol.9, pp.714-717, 1998 (Peer-Reviewed Journal)
1998
1998DİABETES MELLİTUS'UN AKUT METABOLİK KOMPLİKASYONLARI - I :DİABETİK KETOASİDOZ
KAVAKLI B., SARGIN M., GÜMÜŞ M.
Kartal Eğitim ve Araştırma Klinikleri, vol.9, no.4, pp.710-713, 1998 (Peer-Reviewed Journal)
1998
1998BİR İNSÜLİNOMA OLGUSU
Yıldız G., Kavaklı B., GÜMÜŞ M., Küçük H. F. , Salepçi T., Sargın M., et al.
Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, pp.706-709, 1998 (Peer-Reviewed Journal)
1998
1998DİABETES MELLİTUS'UN AKUT METABOLİK KOMPLİKASYONLARI - III: LAKTİK ASİDOZ
KAVAKLI B., SARĞIN M., GÜMÜŞ M.
Kartal Eğitim ve Araştırma Klinikleri, vol.9, pp.718-719, 1998 (Peer-Reviewed Journal)
1997
1997CUSHİNG SENDROMU İLE SEYREDEN BİR SÜRRENAL KARSİNOM OLGUSU
DOLAPCIOĞLU C., KAVAKLI B., TUNCER K., KILIÇ D., AKTUNÇ E., GÜMÜŞ M., et al.
KARTAL EĞİTİM veARAŞTIRMA KLİNİKLERİ, vol.8, no.3, pp.656-659, 1997 (Peer-Reviewed Journal)
1997
1997TIP II DİABETTE BETA STİMÜLAN ORAL ANTİDİABETİK DROGLAR VE KULLANIM ENDİKASYONLARI
KAVAKLI B., KILIÇ D., GÜMÜŞ M.
Kartal Eğitim ve Araştırma Klinikleri, vol.8, pp.661-665, 1997 (Peer-Reviewed Journal)
Refereed Congress / Symposium Publications in Proceedings
2020
2020Patient-reported outcomes (PROs) from IMvigor130: A global, randomised, partially blinded phase III study of atezolizumab (atezo) plus platinum-based chemotherapy (PBC) vs placebo (PBO) plus PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)
Bamias A., De Santis M., Arranz J. A. , Grande E., Galsky M. D. , Kikuchi E., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 September - 18 October 2020, vol.31
2020
2020Health-related quality of life (HRQoL) in KEYNOTE-604: Pembrolizumab (pembro) or placebo added to etoposide and platinum (EP) as first-line therapy for ES-SCLC
Kim H. R. , Awad M. M. , Navarro A., Gottfried M., Peters S., Csoszi T., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 September - 18 October 2020, vol.31
2020
2020EMPOWER-Lung 1: Phase III first-line (1L) cemiplimab monotherapy vs platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) >= 50%
Sezer A., Kilickap S., Gumus M., Bondarenko I., ÖZGÜROĞLU M., Gogishvili M., et al.
ESMO Virtual Congress, ELECTR NETWORK, 19 September - 18 October 2020, vol.31
2019
2019IMvigor130: Efficacy and safety from a phase III study of atezolizumab (atezo) as monotherapy or combined with platinum-based chemotherapy (PBC) vs placebo plus PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)
Grande E., Galsky M., Arranz Arija J. A. , De Santis M., Davis I. D. , De Giorgi U. F. F. , et al.
44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 September - 01 October 2019, vol.30, pp.888-889
2019
2019Neoadjuvant treatment in patients with locally advanced gastric cancer.
Gumus M., Kaya S., Eris S., Alan O., Telli T. A. , Okten I. N. , et al.
Gastrointestinal Cancers Symposium, San-Francisco, Costa Rica, 17 - 19 January 2019, vol.37
2018
2018Health-related quality of life (HRQoL) for pembrolizumab or placebo plus carboplatin and paclitaxel or nab-paclitaxel in patients with metastatic squamous NSCLC: Data from KEYNOTE-407
Mazieres J., Kowalski D., Luft A., Vicente D., Tafreshi A., Gumus M., et al.
43rd ESMO Congress (ESMO), Munich, Germany, 19 - 23 October 2018, vol.29
2018
2018BEP chemotherapy in non-seminomatous testis cancer with multiple liver metastasis: a case report
Şendoğan F., Uçar T., Turan T., GÜMÜŞ M., YILDIRIM A.
8th Eurasian Uro-oncology Congress, 28 June – 1 July 2018, Tiflis, Gürcistan, Tiflis, Georgia, 28 June 2018, pp.279
2018
2018Retroperitoneal sarcomas with 3 cases
Uçar T., Turan T., Toksöz Yıldırım A., GÜMÜŞ M., ÇAŞKURLU T., YILDIRIM A.
8th Eurasian Uro-oncology Congress, 28 June – 1 July 2018, Tiflis, Gürcistan, Tiflis, Georgia, 28 June 2018, pp.296-297
2018
2018The views and practice of oncologists on assessment of nutritional status and provision of nutritional care among cancer patients: A questionnaire-based survey.
GÜMÜŞ M., Evrensel T., Göker E., Mandel N., Özdemir F., Öksüzoğlu B., et al.
ASPEN 2018, Las Vegas, United States Of America, 22 January 2018, vol.0, no.0, pp.77
2017
2017Anxiety And Depressıon In Cancer Dıseases
ÇİL AKINCI A., COŞAR ÇETİN F., TUNA R., GÜMÜŞ M.
2nd International Science Symposium-Science Festival, ISS2017, Tiflis, Georgia, 05 September 2017, pp.71
2017
2017Kanserli Hasta Eşlerinin Bakımverme Yükü
ÇİL AKINCI A., TUNA R., GÜMÜŞ M.
I. Uluslararası Sağlık Bilimleri Kongresi, Aydın, Turkey, 29 June 2017, pp.199
2017
2017Outcomes of Turkish National Breast Cancer Registry.
KILICKAP S., Gumus M., UNCU D., OZKAN M., CICIN I., ELKIRAN T. E. , et al.
53rd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2 - 06 June 2017, vol.35
2017
2017EGFR-targeted treatments in patients with metastatic colorectal cancer: Experience of panitumumab.
Gumus M., GEREDELI C., UCAR M., KAYA S., DEMIR H., UNAL O. U. , et al.
53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35
2017
2017Characteristics of Turkish colorectal cancer patients and bevacizumab preference.
CICIN I., Gumus M., UNCU D., OZKAN M., KILICKAP S., ELKIRAN T. E. , et al.
53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35
2017
2017Metastatik dev renal kitlelerde hedefe yönelik tedavi çağında sitoredüktif nefrektomi: olgu sunumu
Çulpan M., Turan T., Danacıoğlu Y. O. , GÜMÜŞ M., Atış R. G. , ÇAŞKURLU T., et al.
7. Üroonkoloji Kongresi, Edirne, Turkey, 26 January 2017, pp.70
2016
2016The relationship between pretreatment positron emission tomography (PET) results and demographic, histopathologic parameters in patients with locally advanced breast cancer.
Gumus M., Kaya S., Odabas H., Aytekin A., Yildirim N., Sakalar T., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34
2016
2016Outcomes of surveillance VS. adjuvant chemotherapy for patients with STAGE IA and IB NON-seminomatous testicular germ-cell tumors.
Bilici A., Gumus M., Odabas H., Kandemir N., Demirci U., Cihan S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34
2016
2016Changes in 18F-FDG-PET/CT tumor metabolism and prediction of pathologic complete response rates after neoadjuvant chemotherapy in hormone-positive breast cancer.
Kaya S., Aktas B., Simsek E. T. , Ozturk M. A. , Dede F., Kaya H., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34
2016
2016The factors affecting pathologic complete response after neoadjuvant chemotherapy and the role of 18-FDG-PET/CT in patients with locally advanced breast cancer.
Dane F., Kaya S., Odabas H., Aytekin A., Yildirim N., Coban E., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 3 - 07 June 2016, vol.34
2015
2015Metacognitive processes in cancer patients
MUTLU H. H. , MUTLU H. H. , SELEK S., MAYADAGLI A., TURK H. M. , SEKER M., et al.
European Cancer Congress, Vienna, Austria, 01 January 2015, vol.51
2015
2015Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey
CELIK I., MANDEL N. M. , GOKMEN E., UNAL O. U. , SEVINC A., COSKUN H. S. , et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33
2015
2015What are the differences between young (25 years) and adults (> 25 years) colorectal cancer (CRC)? An Anatolian Society of Medical Oncology Study.
KAPLAN M. A. , URAKCI Z., Gumus M., ARSLAN U. Y. , GEREDELI C., OZDEMIR N., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33
2015
2015Turkish National Colon Cancer Registry.
Benekli M., Dumanli E., Kilickap S., Uncu D., Aliustaoglu M., Cicin I., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33
2015
2015Geographic variations of clinical characteristics in breast cancer: Analysis of Turkish National Breast Cancer Registry.
KILICKAP S., ALTUNDAG K., DUMANLI E., Gumus M., USLU R., OZYILKAN O., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33
2015
2015Association of obesity with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry.
Coskun U., Altundag K., Aliustaoglu M., Uncu D., Ozkan M., Cicin I., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33
2015
2015Effect of body mass index in gastric cancer patients: Analysis of Turkish national gastric cancer registry
CILTAS A., KARACA M., UNCU D., OZKAN M., ALIUSTAOGLU M., Tekin S. B. , et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33
2015
2015Association of age with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry.
BENEKLI M., ALTUNDAG K., DUMANLI E., ISIKDOGAN A., KARAOGLU A., Tekin S. B. , et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33
2015
2015Turkish National Gastric Cancer Registry.
Buyukberber S., Dumanli E., Uncu D., Ozkan M., Uslu R., Dogu G. G. , et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33
2015
2015Results of observational study to determine K-ras mutation rates in 2458 patients with metastatic colorectal cancer in Turkey (TURKRAS Study).
Gumus M., DANE F., KARABULUT B., UYGUN K., AYDIN K., ORHAN B., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33
2015
2015Turkish National Breast Cancer Registry.
ALTUNDAG K., DUMANLI E., ALIUSTAOGLU M., UNCU D., OZKAN M., CICIN I., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, United States Of America, 29 May - 02 June 2015, vol.33
2015
2015LOKAL İLERİ PANKREAS KANSERİ TEDAVİSİNDE KAPESİTABİN BAZLI KEMOTERAPİ İLE HİPERFRAKSİYONE RADYOTERAPİNİN GÜVENİLİRLİĞİ-PİLOT ÇALIŞMA
Akgün Z., Güral Z., Süt P., SEKER M., MAYADAGLI A., TURK H. M. , et al.
21.Ulusal Kanser Kongresi, Antalya, Turkey, 22 April 2015, pp.522
2014
2014THREE DIFFERENT CHEMOTHERAPY COMBINATIONS WITH CONCURRENT THORACIC RADIATION FOR PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER
OZCELIK M., BALVAN ERCELEP O., GUVEN MERT A., YUKSEL S., OZDEMIR P., SURMELI H., et al.
39th ESMO Congress (ESMO), Madrid, Spain, 26 - 30 September 2014, vol.25
2014
2014EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER
SENDUR M. A. , AKSOY S., UNCU D., Demir H., YUKSEL S., EKINCI A. S. , et al.
39th ESMO Congress (ESMO), Madrid, Spain, 26 - 30 September 2014, vol.25
2014
2014The clinical and pathologic characteristics of 400 gastrointestinal stroinal tumor patients from Turkey: The final results of the Turkish Anatolian Society of Medical Oncology Multicenter Registery
SEVINC A., SEKER M., YILDIZ R., CIHAN S., KAPLAN M. A. , DANE F., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32
2014
2014Treatment and prognosis in mucosal. melanoma: An Anatolian Society of Medical Oncology Study.
ERCELEP O., EKINCI A. S. , BAYOGLU I. V. , UZUNOGLU S., ULAS A., BOZKURT O., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32
2014
2014Turkish Breast Cancer Registry: A multicenter epidemiologic study
COSKUN U., Gumus M., UNCU D., OZKAN M., CICIN I., ALTUNDAG K., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, United States Of America, 30 May - 03 June 2014, vol.32
2013
2013The Social Phobia Trend of in University Students
YANIK A., Bor E., Baydeniz S., Kudret S., Tekin İ., Boz H., et al.
Vlll. German-Turkish Congress of Psychiatry, İzmir, Turkey, 18 September 2013
2013
2013The evaluation of factors predicting recurrence and prognosis for patients with node-negative gastric cancer after curative resection
BILICI A., SELCUKBIRICIK F., USTAALIOGLU B. B. , SEKER M., DANE F., ALIUSTAOGLU M., et al.
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 27 September - 01 October 2013, vol.49
2013
2013The changing of serum vitamin B12 and homocysteine levels after gastrectomy in patients with gastric cancer: Do they associate with clinicopathological factors?
Bilici A., Sonkaya A., Ercan S., Ustaalioglu B. B. , Seker M., Aliustaoglu M., et al.
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 27 September - 01 October 2013, vol.49
2013
2013Interim results of observational study to determine K-ras mutation rates in patients with metastatic colorectal cancer in Turkey (TURKRAS study)
Gumus M., DANE F., KARABULUT B., UYGUN K., ORHAN B., AYDIN K., et al.
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 27 September - 01 October 2013, vol.49
2013
2013The prognostic impact of survivin and REG1A in diffuse large B-cell lymphoma
SEKER M., Gumus M., BARISIK N. O. , DANE F., BOZKURT S., BILICI A., et al.
European Cancer Congress 2013 - 17th ECCO / 38th ESMO / 32nd ESTRO, Amsterdam, Netherlands, 27 September - 01 October 2013, vol.49
2013
2013The relationship between collapsin response mediator protein-1 (CRMP 1) expression and histopathogic parameters and survival in patient with gastric cancer.
Gumus M., YASAR N., KAYAHAN S., YUKSEL S., BALVAN O., MERT A. G. , et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31
2013
2013Efficacy and safety results of pemetrexed administration in non-small cell lung cancers, a multicenter study of the Association of Anatolian Medical Oncology.
YASAR N., UNAL O. U. , GEREDELI C., INAL A., BERK V., SARI E., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31
2013
2013Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer.
BILICI A., SELCUKBIRICIK F., USTAALIOGLU B. B. O. , TURAL D., SEKER M., Gumus M., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31
2013
2013The relationship between tumor markers and histopathologic and demographic features of patients with breast cancer and their distinctive role in metastatic process.
AYDIN K., UYGUR M. M. , ODABAS H., KORKMAZ T., YASAR N., DINC N., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31
2013
2013Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.
Turan N., Dane F., Unal O. U. , Benekli M., Kara H. V. , Koca D., et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31
2013
2013The efficacy and safety of first-line and salvage therapies with bevacizumab combination chemotherapy regimens in metastatic colorectal cancer: A retrospective ASMO experience.
YILDIZ R., BUYUKBERBER S., KOCA D., KORAI L., CILTAS A., UNAL O. U. , et al.
49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 31 May - 04 June 2013, vol.31
2012
2012COMPARISON OF SECOND LINE TREATMENT OUTCOMES BETWEEN SENSITIVE AND REFRACTORY SMALL CELL LUNG CANCER PATIENTS: A RETROSPECTIVE ANALYSIS
Korkmaz T., Seber S., SARI E., Canhoroz M., Ustaalioglu B. O. , Kefeli U., et al.
37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Austria, 28 September - 02 October 2012, vol.23, pp.497-498
2012
2012A COMPARISON OF XELIRI PLUS BEVACIZUMAB WITH FOLFIRI PLUS BEVACIZUMAB AS FIRST-LINE SETTING IN PATIENTS WITH METASTATIC COLORECTAL CANCER
AHMET B., UYGUN K., Kaya S., USTAALIOGLU B. B. O. , YILDIZ R., Temiz S., et al.
14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO), Barcelona, Spain, 27 - 30 June 2012, vol.23, pp.98-99
2012
2012LARGE CELL NEUROENDOCRINE CARCINOMA: RETROSPECTIVE ANALYSIS OF 24 CASES FROM 4 ONCOLOGY CENTERS IN TURKEY
Ustaalioglu B. B. O. , Ulas A., Ozturk G., Turan N., Bilici A., Demirci U., et al.
3rd European Lung Cancer Conference (ELCC), Geneva, Switzerland, 18 - 21 April 2012, vol.7
2012
2012The prognostic value of beta-catenin and LEF-1 expression in patients with gastric carcinoma.
Kaya S., Gumus M., Gurbuz Y., Temiz S., Cabuk D., Acikgoz O., et al.
48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 1 - 06 June 2012, vol.30
2011
2011The Significance of the Changing of Serum M30 and M65 Values After Chemotherapy and Relationship Between These Values and Clinicopathological Factors in Patients With Advanced Gastric Cancer
BILICI A., USTAALIOGLU B. B. O. , ERCAN S., ORCUN A., SEKER M., SALEPCI T., et al.
European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care, Stockholm, Sweden, 23 - 27 September 2011, vol.47
2010
2010SERUM M30 AND M65 VALUES IN PATIENTS WITH ADVANCED STAGE NON-SMALL CELL LUNG CANCER COMPARED WITH HEALTHY CONTROL GROUP
Ustaalioglu B. O. , Bilici A., Ercan S., Orcun A., Seker M., Kefeli U., et al.
35th European-Society-for-Medical-Oncology (ESMO) Congress, Milan, Italy, 8 - 12 October 2010, vol.21, pp.72-73
2010
2010PLASMA M30 AND M65 LEVELS IN PATIENTS WITH ADVANCED GASTRIC CANCER: IS THERE AN IMPACT ON SURVIVAL OF PATIENTS?
BILICI A., USTAALIOGLU B. B. O. , ORCUN A., ERCAN S., SEKER M., KEFELI U., et al.
35th European-Society-for-Medical-Oncology (ESMO) Congress, Milan, Italy, 8 - 12 October 2010, vol.21, pp.48
2010
2010TAXANE-BASED TREATMENT OPTIONS FOR PATIENTS WITH HER2-POSITIVE ADVANCED BREAST CANCER: RESULTS OF AN OBSERVATIONAL STUDY
Gumus M., DAVIDSON N., HURTADO DE MENDOZA F., BRYCHTA M., DONADIO M., KRAL A., et al.
35th European-Society-for-Medical-Oncology (ESMO) Congress, Milan, Italy, 8 - 12 October 2010, vol.21, pp.103
2010
2010CLINICAL ROLE OF 18F-FDG-PET/CT IN THE ASSESSMENT OF SUSPECTED RECURRENT GASTRIC CANCER AFTER INITIAL SURGICAL RESECTION: IS THERE ANY EFFECT OF FDG-PET/CT IN PATIENTS' MANAGEMENT?
BILICI A., SEKER M., OVEN U. B. , CANPOLAT N., TEKINSOY B., SALEPCI T., et al.
12th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 30 June - 03 July 2010, vol.21, pp.84
2010
2010THE EFFECT OF TUMOR SIZE ON OVERALL SURVIVAL IN PATIENTS WITH PT3 GASTRIC CANCER WHO UNDERWENT CURATIVE GASTRECTOMY
Bilici A., UYGUN K., Seker M., Aliustaoglu M., Temiz S., Oven U. B. , et al.
12th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 30 June - 03 July 2010, vol.21, pp.45
2010
2010COEXISTENCE OF GASTROINTESTINAL STROMAL TUMORS WITH OTHER NEOPLASMS
Seker M., Sevinc A., Bilici A., Ozdemir N., Yildiz R., Kalender M., et al.
12th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 30 June - 03 July 2010, vol.21, pp.57
2010
2010THE IMPORTANCE OF LIVER METASTASECTOMY IN METASTATIC COLORECTAL CANCER PATIENTS: SINGLE CENTER EXPERIENCES
USTAALIOGLU O. B. , SEKER M., BILICI A., SALEPCI T., KEFELI U., ONCEL M., et al.
12th World Congress on Gastrointestinal Cancer, Barcelona, Spain, 30 June - 03 July 2010, vol.21, pp.68
2009
2009Immunohistochemically Defined T1N0 Breast Cancer Subgroups Have Different Clinical Outcomes. A Retrospective Turkish Oncology Group Study
BASARAN G., OKKAN S., CAGLAR H., BENEKLI M., Gumus M., HAYDAROGLU A., et al.
32nd Annual San Antonio Breast Cancer Symposium, San-Antonio, Northern Mariana Islands, 9 - 13 December 2009, vol.69
2009
2009The effect of peripheral blood values before treatment on prognosis of patients with locally advanced gastric cancer
Aliustaoglu M., Bilici A., Ustaalioglu B. B. O. , Konya V., Gucun M., Seker M., et al.
15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology, Berlin, Germany, 20 - 24 September 2009, vol.7, pp.381
2009
2009Factors affecting type of surgical treatment in patients with breast cancer
GARIP M., Gumus M., DANE F., SEKER M., BILICI A., USTAALIOGLU B. O. , et al.
45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 29 May - 02 June 2009, vol.27
2009
2009Single-center experiences of neoadjuvant systemic therapy in breast cancer: Individualization of the treatment
Gumus M., USTAALIOGLU B. O. , SEKER M., BILICI A., SALMAN T., SOENMEZ B., et al.
45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 29 May - 02 June 2009, vol.27
2009
2009Weight gain after adjuvant treatment in breast cancer patients in Istanbul, Turkey
Turhal N. S. , Yurt N., Yurtseven G., Cabuk D., Teomete M., GÜMÜŞ M.
45th Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 29 May - 02 June 2009, vol.27
2009
2009REGATE: Global Mide Kanseri Kayıt Çalışması Türkiye Verileri
Yalçın Ş., GÜMÜŞ M., Kılıçkap S., Alkış N., Alkış N., Alkış N., et al.
18.Ulusal Kanser Kongresi, Antalya, Turkey, 21 April 2009, pp.17
2008
2008THE ROLE OF ANGIOTENSIN II IN THE ETIOLOGY OF ARTERIAL VASOCONSTRICTION INDUCED BY 5-FLUOROURACIL
OZTURK A., SALEPCI T., SEKER M., Gumus M., UYAREL H., USTAALIOGLU B. B. O. , et al.
33rd European-Society-for-Medical-Oncology Congress, Stockholm, Sweden, 12 - 16 September 2008, vol.19, pp.59
2006
2006Rituximab-CHOP versus CHOP alone in patients with diffuse large B cell lymphoma.
CETINER M., Salepçi T., ATESOGLU E. B. , Gumus M., GUVEN A., UNDAR L., et al.
48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108
2006
2006Outcome of adjuvant treatment in turkish breast cancer (BC) patients (PTS): Single institution experience
CABUK D., BASARAN G., İYİKESİCİ S., EKENEL M., DANE F., TEOMETE M., et al.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.109
2006
2006Use of new chemotherapy agents in metastatic breast cancer
OZDEN S. A. , OZGEN Z., OZYURT H., Salepçi T., Gumus M., DIZDAR N., et al.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.92
2006
2006Outcome of metastatic colorectal cancer patients receiving palliative chemotherapy in Marmara University Hospital
DANE F., YUMUK F., Gumus M., İYİKESİCİ S., TUFAN A., BASARAN G., et al.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.129
2006
2006Association between presence of HPV DNA and P53 in breast cancer patients
YUMUK P. F. , Gumus M., KAYA H., ALAM K., DANE F., Güllüoğlu B., et al.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.110-111
2006
2006Outcome of colon cancer patients receiving adjuvant chemotherapy in Marmara University Hospital
DANE F., Gumus M., YUMUK P. F. , İYİKESİCİ S., OZTURK A., BASARAN G., et al.
31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.130
2005
2005P53 Her2/neu as prognostic factors in advanced non-small cell lung cancer (NSCLC) treated with paclitaxel
YUMUK R., TURHAL N., AHISKALI R., Gumus M., HATABAY N., TURKEN O., et al.
11th World Conference on Lung Cancer, Barcelona, Spain, 3 - 06 July 2005, vol.49
2005
2005Uracil-tegafur (UFT) based radiochemotherapy in adjuvant treatment of resected high risk gastric cancer.
GEMICI C., DEMIR O., SALEPCI T., Gumus M., MAYADAGLI A., SESEOGULLARI O.
41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 13 - 17 May 2005, vol.23
2005
2005Outcome of elderly patients with advanced non-small cell lung cancer.
Gumus M., PALAK B., IYIKESICI S., YUMUK P., SEKER M., TOPAL A., et al.
41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 13 - 17 May 2005, vol.23
2004
2004Prognostic value of thymidylate synthase and cox-2 expression in colorectal cancer patients' tumors.
ALIUSTAOGLU M., Gumus M., MIDI A., CELIKEL C., EKENEL M., YUMUK F., et al.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 5 - 08 June 2004, vol.22
2004
2004Impact of INT-0116 Trial on adjuvant treatment of gastric cancer
GEMICI C., MAYADAGLI A., SALEPCI T., TUGRUL F., PARLAK C., Gumus M., et al.
40th Annual Meeting of the American-Society-of-Clinical-Oncology, Louisiana, United States Of America, 5 - 08 June 2004, vol.22
2004
2004